Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 229

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting

Open access
Sánchez-Abarca, Luis I., Gutierrez-Cosio, Silvia, Santamaría, Carlos, Caballero-Velazquez, Teresa, Blanco, Belen, Herrero-Sánchez, Carmen, García, Juan L., Carrancio, Soraya, Hernández-Campo, Pilar, González, Francisco J., Flores, Teresa, Ciudad, Laura, Ballestar, Esteban, del Cañizo, Consuelo, San Miguel, Jesus F., Pérez-Simon, Jose A. · 2010 · Blood

Abstract

Cytokine genes are targets of multiple epigenetic mechanisms in T lymphocytes. 5-azacytidine (5-azaC) is a nucleoside-based DNA methyltransferase inhibitor that induces demethylation and gene reactivation. In the current study, we analyzed the effect of 5-azaC in T-cell function and observed that 5-azaC inhibits T-cell proliferation and activation, blocking cell cycle in the G0 to G1 phase and decreasing the production of proinflammatory cytokines such as tumor necrosis factor-α and interferon-γ. This effect was not attributable to a proapoptotic effect of the drug but to the down-regulation of genes involved in T-cell cycle progression and activation such as CCNG2, MTCP1, CD58, and ADK and up-regulation of genes that induce cell-growth arrest, such as DCUN1D2, U2AF2, GADD45B, or p53. A longer exposure to the drug leads to demethylation of FOXP3 promoter, overexpression of FOXP3, and expansion of regulatory T cells. Finally, the administration of 5-azaC after transplantation prevented the development of graft-versus-host disease, leading to a significant increase in survival in a fully mismatched bone marrow transplantation mouse model. In conclusion, the current study shows the effect of 5-azaC in T lymphocytes and illustrates its role in the allogeneic transplantation setting as an immunomodulatory drug, describing new pathways that must be explored to prevent graft-versus-host disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2009-03-210393

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 229

Metadata

Authors
Sánchez-Abarca, L. I., Gutierrez-Cosio, S., Santamaría, C., Caballero-Velazquez, T., Blanco, B., Herrero-Sánchez, C., García, J. L., Carrancio, S., Hernández-Campo, P., González, F. J., Flores, T., Ciudad, L., Ballestar, E., del Cañizo, C., San Miguel, J. F., & Pérez-Simon, J. A.
Venue
Blood
Published
2010-01-07
Volume
115
Issue
1
Pages
107-121
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2051877520
Cited by
229
References
4
FWCI
8.32
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. https://app.cochat.ai/papers/10.1182/blood-2009-03-210393
The paper
Sánchez-Abarca, L. I., Gutierrez-Cosio, S., Santamaría, C., Caballero-Velazquez, T., Blanco, B., Herrero-Sánchez, C., García, J. L., Carrancio, S., Hernández-Campo, P., González, F. J., Flores, T., Ciudad, L., Ballestar, E., del Cañizo, C., San Miguel, J. F., & Pérez-Simon, J. A. (2010). Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting. Blood. https://doi.org/10.1182/blood-2009-03-210393

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.